Federico Cappuzzo

Simulation of Aircraft Virtual Architecture - Bleed Off-Take and ECS

Federico Cappuzzo, Olivier Broca, Jeremy Leboi, 2017 .

System Simulation for Autonomous UAV Design*

Federico Cappuzzo, Raphaël Lallement, Guillaume Thalmann, 2021, DroneSE/RAPIDO@HiPEAC.

Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations

Federico Cappuzzo, Paul Delmar, Tudor Ciuleanu, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.

Elisa Rossi, Vienna Ludovini, Lucio Crino, 2005, Journal of the National Cancer Institute.

Atezolizumab for First‐Line Treatment of Metastatic Nonsquamous NSCLC

Federico Cappuzzo, M. Socinski, F. Cappuzzo, 2018, The New England journal of medicine.

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Andreas Sashegyi, Michael Thomas, Federico Cappuzzo, 2014, The Lancet.

Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.

Elisa Rossi, Vienna Ludovini, Lucio Crino, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial.

Federico Cappuzzo, Armando Santoro, Giorgio Brambilla, 2008, Lung cancer.

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Sabine Tejpar, Federico Cappuzzo, Mauro Delorenzi, 2010, The Lancet. Oncology.

Frequent mutations in chromatin-remodeling genes in pulmonary carcinoids

Martin Vingron, Thomas Zander, Viktor Achter, 2014, Nature Communications.

Erlotinib in gliomas: should selection be based on EGFR and Akt analyses?

Federico Cappuzzo, F. Cappuzzo, 2005, Journal of the National Cancer Institute.

Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop

Michael Thomas, Federico Cappuzzo, Manfred Dietel, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.